Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4.50 GBp
Change Today 0.00 / 0.00%
Volume 0.0
VRP On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
As of 2:30 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Patrick Paul Anthony Humphrey B.Pharm. Hons Ph.D., D.Sc OBE

Non-Executive Director, Member of Remuneration Committee and Member of Nomination & Corporate Governance Committee, Verona Pharma plc
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 3 different industries.

See Board Relationships
6928,024 GBP

Background*

Dr. Patrick Paul Anthony Humphrey, B.Pharm. Hons Ph.D D.Sc OBE served as Executive Vice President of Research of Theravance Inc., from April 2002 to 2008. From July 2001 to April 2002, Dr. Humphrey served as Research of Theravance Inc.'s Senior Vice President of Research. He served as a Director of the Glaxo Institute of Applied Pharmacology and Professor of Applied Pharmacology at the University of Cambridge from 1994 to 2001. He was naming of receptors for all hormones ...

Read Full Background

Corporate Headquarters*

3 More London Riverside
London, Greater London SE1 2RE

United Kingdom

Phone: 44 20 3283 4200
Fax: --

Board Members Memberships*

2009-Present
Non-Executive Director, Member of Remuneration Committee and Member of Nomination & Corporate Governance Committee

Education*

PhD
University Of London
ScD
University Of London
Bachelor's Degree 1968
University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options833,334
Unexercisable Options666,666
Total Number of Options1,500,000

Total Compensation*

Total Annual Cash Compensation21,662 GBP
Total Calculated Compensation28,024 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRP:LN 4.50 GBp 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERONA PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.